Table 2.
Renal parameters and inflammatory markers
| Renal Parameters and Inflammatory Markers | No. of Patients (%) | Median | Range |
|---|---|---|---|
| AKI stage | |||
| No AKI | 2/42 (4.8) | ||
| AKI stage 1 | 6/42 (14.3) | ||
| AKI stage 2 | 9/42 (21.4) | ||
| AKI stage 3 | 16/42 (38.1) | ||
| Serum creatinine not available | 9/42 (21.4) | ||
| Proteinuria (dipstick), mg/dla | |||
| <30 | 6/29 (20.7) | ||
| 30 | 6/29 (20.7) | ||
| 100 | 10/29 (34.5) | ||
| 300 | 4/29 (13.8) | ||
| >1000 | 3/29 (10.3) | ||
| No. of nephrotoxin exposures | |||
| 0 | 13/42 (31.0) | ||
| 1 | 17/42 (40.4) | ||
| 2 | 10/42 (23.8) | ||
| 3 | 1/42 (2.4) | ||
| 4 | 1/42 (2.4) | ||
| Inflammatory markers | |||
| Elevated IL-6 (reference range: ≤5 pg/ml)b | 26/26 (100) | >315 | 36 to >315 |
| Elevated high-sensitivity CRP (reference range: 0.00–10.00 mg/L)c | 30/30 (100) | 245.7 | 82.07 to >300 |
| Elevated d-dimer (reference range: ≤0.80 μg/ml FEU)d | 27/28 (96.4) | 10.2 | 0.58 to >20 |
| Abnormal fibrinogen activity (reference range: 191–430 mg/dl)e | 12/14 (92.9) | 456.5 | <60 to 855 |
CRP, C-reactive protein; FEU, fibrinogen equivalent units.
a
Proteinuria was unavailable in 13 patients.
b
IL-6 levels were unavailable in 16 patients.
c
CRP levels were unavailable in 12 patients.
d
d-dimer levels were unavailable in 14 patients.
e
Fibrinogen activity was unavailable in 28 patients.